Sunday, 24 April 2011

Wedederm




Wedederm may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Wedederm



Ichthammol

Ichthammol decolorized (a derivative of Ichthammol) is reported as an ingredient of Wedederm in the following countries:


  • Germany

International Drug Name Search

Acnezoyl




Acnezoyl may be available in the countries listed below.


Ingredient matches for Acnezoyl



Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Acnezoyl in the following countries:


  • Bahrain

International Drug Name Search

Saturday, 23 April 2011

CefpoLEK




CefpoLEK may be available in the countries listed below.


Ingredient matches for CefpoLEK



Cefpodoxime

Cefpodoxime is reported as an ingredient of CefpoLEK in the following countries:


  • Poland

International Drug Name Search

Friday, 22 April 2011

Simvastatine AccordHealthcare




Simvastatine AccordHealthcare may be available in the countries listed below.


Ingredient matches for Simvastatine AccordHealthcare



Simvastatin

Simvastatin is reported as an ingredient of Simvastatine AccordHealthcare in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 19 April 2011

Claritin Eye Allergy Relief




Claritin Eye Allergy Relief may be available in the countries listed below.


Ingredient matches for Claritin Eye Allergy Relief



Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Claritin Eye Allergy Relief in the following countries:


  • Canada

International Drug Name Search

Thursday, 14 April 2011

Méprednisone




Méprednisone may be available in the countries listed below.


Ingredient matches for Méprednisone



Meprednisone

Méprednisone (DCF) is also known as Meprednisone (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 13 April 2011

Striant


Striant is a brand name of testosterone, approved by the FDA in the following formulation(s):


STRIANT (testosterone - tablet, extended release; buccal)



  • Manufacturer: ACTIENT PHARMS

    Approval date: June 19, 2003

    Strength(s): 30MG [RLD]

Has a generic version of Striant been approved?


No. There is currently no therapeutically equivalent version of Striant available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Striant. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Bioadhesive progressive hydration tablets and methods of making and using the same
    Patent 6,248,358
    Issued: June 19, 2001
    Inventor(s): Bologna; William J. & Levine; Howard L. & Cartier; Philippe & de Ziegler; Dominique
    Assignee(s): Columbia Laboratories, Inc.
    A bioadhesive tablet wherein the active ingredient may be protected from water or the surrounding environment, thereby protecting it from metabolism or from other degradation caused by moisture, enzymes, or pH effects, and making it bioavailable only at a controlled rate. The active ingredient may be protected from moisture during the manufacturing process and more importantly may be protected from moisture and the immediate septic environment until after the patient has applied the tablet, and then only at a slow and controlled rate. It is by this process of progressive hydration that the active ingredient remains protected for many hours after administration. It is also by the process of progressive hydration that controlled and sustained release is achieved because only that part of the active ingredient that is the hydrated (aqueous) fraction of the tablet is available for absorption (bioavailable).
    Patent expiration dates:

    • August 23, 2019
      ✓ 
      Patent use: METHOD OF DELIVERING AN ACTIVE INGREDIENT USING A PROGRESSIVE HYDRATION BIOADHESIVE



See also...

  • Striant Consumer Information (Drugs.com)
  • Striant Consumer Information (Wolters Kluwer)
  • Striant Consumer Information (Cerner Multum)
  • Striant Advanced Consumer Information (Micromedex)
  • Testosterone Consumer Information (Drugs.com)
  • Testosterone Consumer Information (Wolters Kluwer)
  • Testosterone Gel Consumer Information (Wolters Kluwer)
  • Testosterone Patch Consumer Information (Wolters Kluwer)
  • Testosterone Solution Consumer Information (Wolters Kluwer)
  • Testosterone buccal system Consumer Information (Cerner Multum)
  • Testosterone injection Consumer Information (Cerner Multum)
  • Testosterone topical Consumer Information (Cerner Multum)
  • Androplex Advanced Consumer Information (Micromedex)
  • Testosterone Buccal Advanced Consumer Information (Micromedex)
  • Testosterone Topical application Advanced Consumer Information (Micromedex)
  • Testosterone Transdermal Advanced Consumer Information (Micromedex)
  • Testosterone AHFS DI Monographs (ASHP)

Tuesday, 5 April 2011

Diprivan




In the US, Diprivan (propofol systemic) is a member of the drug class general anesthetics and is used to treat Anesthesia.

US matches:

  • Diprivan

UK matches:

  • Diprivan 1%
  • Diprivan 2%
  • Diprivan 1% (SPC)
  • Diprivan 2% (SPC)

Ingredient matches for Diprivan



Propofol

Propofol is reported as an ingredient of Diprivan in the following countries:


  • Argentina

  • Australia

  • Austria

  • Bahamas

  • Bahrain

  • Bangladesh

  • Barbados

  • Belgium

  • Bermuda

  • Bulgaria

  • Canada

  • Chile

  • China

  • Colombia

  • Costa Rica

  • Cyprus

  • Czech Republic

  • Denmark

  • Dominican Republic

  • Ecuador

  • Egypt

  • El Salvador

  • France

  • Georgia

  • Ghana

  • Greece

  • Guatemala

  • Guyana

  • Haiti

  • Honduras

  • Hong Kong

  • Hungary

  • Iceland

  • India

  • Indonesia

  • Iraq

  • Israel

  • Italy

  • Jamaica

  • Japan

  • Jordan

  • Kenya

  • Kuwait

  • Latvia

  • Lebanon

  • Libya

  • Luxembourg

  • Malawi

  • Malaysia

  • Malta

  • Mexico

  • Mozambique

  • Netherlands Antilles

  • New Zealand

  • Nicaragua

  • Nigeria

  • Norway

  • Oman

  • Panama

  • Peru

  • Philippines

  • Poland

  • Portugal

  • Qatar

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sri Lanka

  • Sudan

  • Sweden

  • Syria

  • Taiwan

  • Tanzania

  • Trinidad & Tobago

  • Tunisia

  • Uganda

  • United Arab Emirates

  • United Kingdom

  • United States

  • Vietnam

  • Yemen

  • Zambia

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 3 April 2011

Chlorhexidine Irrigation




Chlorhexidine Irrigation may be available in the countries listed below.


Ingredient matches for Chlorhexidine Irrigation



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Chlorhexidine Irrigation in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Saturday, 2 April 2011

Ornitina




Ornitina may be available in the countries listed below.


Ingredient matches for Ornitina



Ornithine

Ornitina (DCIT) is also known as Ornithine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 1 April 2011

Myolax




Myolax may be available in the countries listed below.


Ingredient matches for Myolax



Thiocolchicoside

Thiocolchicoside is reported as an ingredient of Myolax in the following countries:


  • Tunisia

Tolperisone

Tolperisone hydrochloride (a derivative of Tolperisone) is reported as an ingredient of Myolax in the following countries:


  • Bangladesh

International Drug Name Search